Navigation Links
AMG 277 Discriminates Against S1P3 Receptor by 50-fold. S1P1 Lead Compounds Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale. Assets Generated by Epix Pharmaceuticals, Inc. and Amgen.
Date:11/29/2011

WELLESLEY HILLS, Mass., Nov. 29, 2011 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn") Assignee for the Benefit of Creditors of Epix Pharmaceuticals, Inc. ("Epix") announced today that AMG 277 discriminates against S1P3 receptor by 50-fold and that the S1P1 lead compounds will be offered December 8, 2011 in a sealed bid sale.  These assets were generated by Epix Pharmaceuticals, Inc. and Amgen.

AMG 277 has 57-nM functional EC50 for hS1P1 receptor and discriminates against S1P3 receptor by 50-fold.  It displayed efficacy in a DTH model with ED70 of 1.0 mpk.  AMG 277 was tested in FIH-enabling toxicology studies.    

Assets included in the sale include preclinical and toxicology data related to AMG 277, AMG 369 and six backup compounds, existing inventory of these compounds (API), and related patent portfolio.

Persons interested in bidding must sign a Confidentiality Disclosure Agreement ("CDA") obtained from Finn's office – jffinnjr@finnwarnkegayton.com or 781-237-8840; upon receipt of the executed CDA, applicants will receive a bid package, to be completed and returned by December 8, 2011.

About Joseph F. Finn, Jr., C.P.A.

Joseph F. Finn, Jr., C.P.A. is the founding partner of the firm, Finn, Warnke & Gayton, LLP Certified Public Accountants of Wellesley Hills, Massachusetts.  He works primarily in the area of management consulting for distressed enterprises, bankruptcy accounting and related matters, such as assignee for the benefit of creditors and liquidating agent for a corporation.  His most recent Assignments for the Benefit of Creditors in the biotech filed include Spherics, Inc., ActivBiotics, Inc., Prospect Therapeutics, Inc. and Source MDx.

For further information, please contact Joseph F. Finn, Jr., C.P.A. at 781-237-8840 or jffinnjr@finnwarnkegayton
'/>"/>

SOURCE Joseph F. Finn, Jr., C.P.A.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
2. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
3. Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria
4. Molnlycke Drives Home the Fight Against Staph and Other MRSA Infections
5. Mayo Clinic Study Finds FDA Warning Against Anti-Nausea Drug Droperidol Unnecessary
6. Targeted Nanoparticles Offer Promise in the Battle Against Cancer
7. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
8. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
9. Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
10. Semafores PI3 Kinase Inhibitor SF1126 is Active Against Tumor and Tumor Cells and Synergizes with Standard Chemotherapy Agents
11. BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... SAN DIEGO , May 17, 2013 /PRNewswire/ ... today that its Fast-Track Advanced Technology Small Business ... National Institute of Allergy and Infectious Diseases (NIAID), ... (NIH), supporting the development of novel human antibody ... S. aureus or Staph) infections, including methicillin-resistant ...
(Date:5/17/2013)... CHAMPAIGN, Ill. , May 17, 2013  Sony ... new Sony SP6800 Spectral Analyzer (SP6800).  Sony will be ... 2013, which will be held at the ... San Diego, California , from May 20 - ... Sony,s second analytical system, incorporating commercial audio-visual technologies into ...
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- The ... recombinant proteins, is placing renewed emphasis on alternate ... rise as a number of factors are converging ... pharmaceutical makers and their delivery device partners . ... refractory conditions, the growing trend toward self-administration for ...
Breaking Medicine Technology:Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3
... Fla., Oct. 20, 2011 China Nuvo Solar Energy, ... Nevada has approved the Company,s requested corporate name change to ... and authorized the Board of Directors to change the Company,s ... of the Parent. As a result of the Nevada approval, ...
... FREMONT, Calif., Oct. 20, 2011 WaferGen Biosystems, ... announced organizational changes to strengthen domain leadership and ... of its SmartChip System.   As ... Lombardi, formerly President and a director of Helicos ...
Cached Medicine Technology:China Nuvo Solar, Inc. Announces Corporate Name Change to SurgLine International, Inc. 2WaferGen Announces Organizational Changes to Enhance Commercialization of SmartChip System 2WaferGen Announces Organizational Changes to Enhance Commercialization of SmartChip System 3
(Date:5/20/2013)... York, NY (PRWEB) May 20, 2013 ... York City, today announced the introduction of its new ... powder that provides high density nutrition with plant extracts ... vegetables, herbs, spices, royal jelly, apple pectin, plant enzymes ... Hx™ offers the micronutrients and antioxidant levels of several ...
(Date:5/20/2013)... Hills, Utah (PRWEB) May 20, 2013 As a ... can be to effectively balance family, work, and a fit, healthy ... weight gain. , “It hit me like a ton of bricks ... Arnold. “I woke up one morning and realized I had lost ... time. I felt awful, I had little to no energy to ...
(Date:5/19/2013)... New York, NY (PRWEB) May 20, 2013 ... announce that they are representing a New York woman in ... running back with the National Football League (NFL). According ... Court, the Petitioner is seeking a declaration of paternity, order ... on behalf of her son with Mr. Walker. (Docket ...
(Date:5/19/2013)... Calif., May 20, 2013 Whole-cell pertussis vaccines ... acellular pertussis vaccines during a large recent outbreak, ... in Pediatrics . , Whole-cell pertussis vaccines, ... to 1990s, but were associated with safety concerns ... pertussis vaccines, which are also called DTaP. By ...
(Date:5/19/2013)... Alonso Krangle LLP a dedicated law ... lawsuit on behalf of a-24-year-old financial analyst rendered quadriplegic ... The diving accident lawsuit, which was filed in the Supreme ... Defendant held the property out as a bathing beach, but ... area. (Case No. 34556/12) , According to the diving accident ...
Breaking Medicine News(10 mins):Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 2Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 3Health News:New Program Helps Busy Moms Become Healthier, Lose Weight, and Feel Great 2Health News:New York Woman in Paternity Petition Against Former NFL Running Back, Herschel Walker, Alonso Krangle LLP Representing Petitioner 2Health News:New York Woman in Paternity Petition Against Former NFL Running Back, Herschel Walker, Alonso Krangle LLP Representing Petitioner 3Health News:Whole-cell vaccine was more effective than acellular vaccine during CA pertussis outbreak 2Health News:Whole-cell vaccine was more effective than acellular vaccine during CA pertussis outbreak 3Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 2Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 3
... Ulagu”,Wondering what the above verses from Thirukurral written by ... special report about nanotechnology? // , ,“ Annuvai ... the ingenuity of its author, that he has compressed ... as if he had hollowed an atom, and enclosed ...
... proposes to change the curriculum for medicine by integrating ... within two years., ,"Today's medical curriculum is ... the modern and traditional practices in the new curriculum. ... time," said health minister, Ramadoss during National Seminar on ...
... men and occurs in men 65 years or older. It ... should undergo the routine examination of prostate and also test ... levels of PSA in blood. African-American men or men with ... screening exams at an earlier age. Signs and symptoms of ...
... that more and more women are now opting for ... new study in the September issue of the journal ... delivery become more varied and sophisticated, growing numbers of ... childbirth., ,Researchers from the University of Colorado had ...
... acne for more than six weeks were more than ... infection within one year as individuals with acne who ... study reports., ,Overuse of antibiotics has been held ... increase in increase in infectious illness. The present study ...
... is a genetic disorder characterized by distorted, sickle shaped red ... and organ damage to the kidneys, spleen, and liver. The ... the incidence is about 1 in 500., ,Despite much ... disease. Pain can be relieved, and the frequency and duration ...
Cached Medicine News:Health News:Scientists Consider About New Technology Called Nanotechnology 2Health News:Hydroxyurea Treatment For Children With Sickle Cell Disease 2
... table that performs as well as your ... use in major surgical suites where control ... B 810 brings better patient outcomes within ... articulation for maximum patient positioning and allows ...
Clearview Chlamydia is a rapid, easy-to-use test for the detection of Chlamydia trachomatis from female endocervical swab specimens....
10-mm (0.4-in) diameter cups have multi-color lead wires and 2-mm (0.08-in) holes for easy paste/collodion application. Available in a variety of lengths to suit many different needs....
... these head cap systems are packaged to ... Each Electro-Cap System features pure tin electrodes ... When you place your order, please specify ... head cap system and whether you want ...
Medicine Products: